Newly-formed Brane Discovery has licensed a Parkinson's research
programme to become the third company in three years to own the
potentially first-in-class drug candidates.
DeltaDOT has been given a government grant to commercially develop
a new tool to allow researchers to reduce dramatically the time it
takes to weed out unsuitable drug candidates.
The pharmaceutical and healthcare industries will help to push
trade between India and the United Kingdom up by 60 per cent within
three years, claims a soon-to-be released report.
The latest ethical reputations of the world's largest
pharmaceutical companies have been revealed, with GlaxoSmithKline
(GSK) emerging as big pharma's Mother Theresa, according to a
recently-released compilation by Geneva-based...
China has today sentenced to death the former director of its State
Food and Drug Administration (SFDA), on charges of corruption,
according to reports in the Chinese media.
After months of speculation and bartering following Merck KGaA's
decision to put its generics arm up for sale, the winning bid has
finally been announced, with US firm Mylan Laboratories emerging
victorious beating off the competition...
A new market-oriented approach to product development, more
favourable licensing arrangements, strategic acquisitions and a
fresh crop of proprietary drug-delivery technologies helped UK
company BioProgress to deliver an adjusted...
Biovitrum, China Biopharma, Molecular Insight Pharmaceuticals,
Pipex Pharma and CH2M Hill have all had people on the move in the
world of pharmaceutical manufacturing.
Now is an ideal time for small biotechs to ink that perfect deal
with big pharma, attendees heard at the recently held Biotrinity
conference in Oxfordshire, UK.
Evotec is willing to accept significant losses, at least in the
short term, as it moves from being solely a service provider, to
having its own drug development programme as well.
The FDA is giving contract research organisations (CROs) the chance
to take part in a pilot designed to test the viability of
electronic case report forms (eCRF).
An innovative new platform technology with a myriad of applications
has been developed by a UK firm, and promises to be a novel arrow
in the quiver of the pharma industry in its attempts to shoot down
drug counterfeiters.
Albany Molecular Research, Ranbaxy Laboratories, IBS Pharma, PhRMA
and Globalpharma have all had people on the move in the world of
pharmaceutical manufacturing.
Pharmaceutical manufacturer Zentiva has signed a deal acquiring 75
per cent of Turkish Eczacibasi's generic pharmaceuticals business
for €460m, making it the third largest generics company in the
country.
AstraZeneca has this week announced 700 job losses the firm's
Macclesfield site in the UK. Representing over a quarter of the
site's workforce, the cuts come as part of the rationalisation plan
announced by the firm at the...
Indian chemical firm Syschem is planning to splash out up to $15m
(€11.4m) over two years to expand its manufacturing capacity – a
move the company said will facilitate its smooth entry into the
pharma industry and help cope with...
As much of the pharma industry looks to refocus its research and
development, speciality companies can take advantage of compounds
dropped in the reshuffle.
Roche is the latest large pharma company to restructure its
research and development into smaller disease-specific divisions to
help get drugs on the market faster.
As SR Pharma and Quark Biotech start clinical trials of a drug that
uses a Nobel Prize winning technique to 'silence' disease-causing
genes, the largest pharma firms are keen to grab a piece of the
action.
Pharma giant AstraZeneca last week announced its intention to cut
3,000 jobs in an effort to increase productivity and reduce costs.
The company is the latest big pharma to trim its workforce as the
industry readjusts in a more challenging...
A tool that predicts which experimental drugs will ultimately be
approved for release could cut development costs by nearly 40 per
cent, saving pharma companies hundreds of millions per new drug.
Amid 3,000 job cuts, AstraZeneca has invested in hepatitis, obesity
and pulmonary disease drugs as part of a continuing effort to
restructure its business.
After having to abandon a promising experimental hepatitis C
vaccine and shedding over a fifth of its workforce, Coley
Pharmaceutical has announced it will look to outsource future drug
discovery.
UK biotech company Verona Pharma has contracted fellow UK firm Onyx
to manufacture supplies of its new hay fever drug candidate for
forthcoming preclinical and clinical studies.
Shipping giant DHL has bagged a lucrative contract with pharma
giant Wyeth and become the first logistics provider to be given
complete responsibility for a company's worldwide clinical trial
materials distribution.
MDS has announced it will help its customers confirm or repeat
analyses done at its contract research facilities in Quebec, after
the Food and Drug Administration (FDA) urged some drug makers to
retest products because of concerns...
Singapore is planning to double the number of clinical trials it
runs over the next five year, particularly in early phase research,
as it looks to hold its ground amidst industry explosion in the
Asia Pacific.
The nature of patient compliance as the weak link in controlling
clinical trials is set to drive the growing interest of drug
developers and in particular contract research organisations (CROs)
for new technologies that improve compliance,...
A new report out this week suggests the pharma industry is losing
the trust of its key stakeholders. The report, compiled by
PricewaterhouseCoopers (PwC), concludes that the growing decline in
the pharmaceutical industry's reputation...
The use of virtual patients to simulate clinical trials on
computers can forecast their results, potentially optimising drug
development and saving the pharmaceutical industry billions.
Despite the many challenges facing the pharma industry, drug
developers should be optimistic, and one of the reasons is the
increasing reliance on global outsourcing to speed development and
reduce costs, says new report.
India's drug manufacturing industry is tipped to grow 10 per cent
over the next three years as more pharma firms shift operations
there to cut costs, says a research report.
Despite the many challenges facing the pharmaceutical industry,
drug developers should be optimistic, according to a report from
the Tufts Center for the Study of Drug Development (CSDD).
A US government report has warned that the pharmaceutical industry
is not producing enough new drugs despite spending more on research
and development.
The pharmaceutical industry's first fully portable drug
anti-counterfeiting device will be presented in Baltimore later
this month at IFPAC, the International Forum on Process Analytical
Chemistry.
In the next one to two years there will be a trend towards
significant reductions in clinical outsourcing/contract research
organisation (CRO) budgets in the majority of biopharma firms,
reveals a recent industry survey.
A UK based firm aims to take up the fight against drug
counterfeiters with its innovative imaging and spectroscopy
products. TeraView says its technology could aid regulators and law
enforcement agencies screen for potentially lethal...
Actavis has announced its majority purchase of Russian
pharmaceutical manufacturer, ZiO Zdorovje, in a move set to
establish the company's presence in the growing Russian generics
market.
US-based drug maker Merck, has agreed to outsource some of its
preclinical trial work to an Indian-based company, marking the
first time the pharma giant has used an Indian company to conduct
drug research.